Navigation Links
Medizone International, Inc. Approves Repurchase of Global Marketing Rights

SAN FRANCISCO, Dec. 16 /PRNewswire-FirstCall/ -- Medizone International, Inc. (OTC Bulletin Board: MZEI) reported that its Board of Directors and the Board of Medizone New Zealand Ltd., a joint venture in which Medizone International Inc. holds a 50% interest, agreed on December 14, 2009 to unwind the joint venture and reconvey to Medizone International all global marketing rights of the company's intellectual property. Medizone International's Chairman, Edwin G. Marshall said, "Time has eroded the relevance of the joint venture we established in 1995 and the partnership no longer fits with the business plan of Medizone International moving forward. We have mutually agreed that it is in the best interest of both Medizone New Zealand Ltd., and Medizone International, Inc., to find a fair basis to terminate the marketing rights and to wind up the joint venture." The transaction should be concluded by December 31, 2009.

The parties agreed that Medizone International Inc. would pay Solwin Investments Ltd., the New Zealand principal in Medizone New Zealand Ltd. $125,000 in shares of Medizone International common stock priced at $0.40 per share, $0.015 above the closing market price on the day agreement was reached. The joint venture held licensing and marketing rights for Medizone products in Australia and its territories, New Zealand and its territories, the South Pacific Islands, the Philippines, Indonesia, Viet Nam, Cambodia, Laos, Thailand, Malaysia and Singapore. Noted Marshall, "In recapturing all marketing and licensing rights to these territories, Medizone International now retains global marketing and licensing rights for all of its future products, paving the way for implementation of its revised business plan."

Medizone International, Inc., is a research and development company engaged in developing its AsepticSure(TM) technology to decontaminate and sterilize hospital surgical suites, emergency rooms, intensive care units, schools and other critical infrastructure. Full-scale mock-up trials are scheduled to begin in January at its research laboratories located in Innovation Park, Queens University in Kingston, Ontario, Canada.

This Press Release contains certain forward looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company's filings made with the Securities and Exchange Commission.

           Investor Relations: 415-868-0300 / web site:

SOURCE Medizone International, Inc.

SOURCE Medizone International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Medizone International, Inc. Announces OTCBB Listing
2. Medizone Expects OTCBB Listing
3. Medizone International, Inc. Has Filed for Patent Protection for Its AsepticSure(TM) Hospital Sterilization System
4. Medizone International, Inc. (MZEI.PK) Announces it has Established its Own BSL2A Certified Laboratory Located in Innovation Park, Queens University at Kingston, Ontario, Canada.
5. Medizone Announces That Its AsepticSure(TM) Development Program is Reaching Objectives on Two Fronts
6. Medizone Announces a Second Round of Trials Have Begun.
7. The Canadian Foundation for Global Health Announces a Research and Development Partnership with Medizone International, Inc.
8. Medizone International, Inc. Announces Strategic Consulting Relationship With TDV Global, Inc.
9. AirMed International, Top U.S. Air Ambulance, Receives EURAMI Accreditation
10. Natural Alternatives International, Inc. Announces Fiscal 2009 Q4 and Full Year Results
11. CEO and Founder of Project Lifesaver International, Gene Saunders, Selected to Receive Two Awards From Local Community
Post Your Comments:
(Date:11/27/2015)... CA (PRWEB) , ... November 27, 2015 , ... According ... at the recent 2015 American Dental Association meeting in Washington D.C. revolved around the ... protect a patient’s overall health. The talk stressed the link between periodontal disease (more ...
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss doctors has released ... Surviving Mesothelioma has just posted the findings on the website. Click here to ... cases of 136 mesothelioma patients who were treated with chemotherapy followed by EPP surgery. ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... edition of USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with ... digital component is distributed nationally, through a vast social media strategy and across ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... well-respected Microsoft Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official group for ... of Microsoft Dynamics SL software users, partners, industry experts and representatives. Intellitec Solutions’ ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... CBD ... Accreditation of Allied Health Education Programs (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography ... CAAHEP accredited colleges, as only one of twelve colleges and universities in the state ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , Países Bajos, November 26, 2015 ... la terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... la inmunoterapia con la terapia fotodinámica de Bremachlorin para ... Un nuevo enfoque combina la inmunoterapia con la terapia ... Clinical Cancer Research . --> ...
(Date:11/26/2015)... , Nederland, November 26, 2015 ... Een nieuwe aanpak combineert immunotherapie met ... kanker. ) ...      (Photo: ) ... Leids Universitair Medisch Centrum (LUMC) ...
(Date:11/26/2015)... 3D bioprinting market is expected to reach ... by Grand View Research Inc. Rising prevalence of chronic diseases ... is expected to boost the market growth, as 3D bioprinting ... --> 3D bioprinting market is expected to reach ... by Grand View Research Inc. Rising prevalence of chronic diseases ...
Breaking Medicine Technology: